What is the protocol for managing Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management Protocol for DKA and HHS

Begin immediate fluid resuscitation with isotonic saline (0.9% NaCl) at 15-20 mL/kg/h during the first hour for both DKA and HHS, followed by continuous IV insulin for DKA (after confirming potassium >3.3 mEq/L), while delaying insulin in HHS until osmolality stops declining with fluids alone unless ketonemia is present. 1, 2

Diagnostic Criteria

DKA Diagnosis

  • Blood glucose >250 mg/dL 1
  • Arterial pH <7.3 1, 3
  • Serum bicarbonate <15 mEq/L 1, 3
  • Moderate ketonuria or ketonemia 1
  • Anion gap >10-12 mEq/L 3

HHS Diagnosis

  • Blood glucose >600 mg/dL 1
  • Arterial pH >7.3 1
  • Serum bicarbonate >15 mEq/L 1
  • Effective serum osmolality ≥320 mOsm/kg (calculated as 2×Na+ + glucose + urea) 1, 2
  • Only small ketones (≤3.0 mmol/L) 2

Essential Initial Laboratory Tests

  • Arterial blood gases for pH documentation 3
  • Measure β-hydroxybutyrate specifically—never rely on nitroprusside-based tests for monitoring 3
  • Electrolytes with calculated anion gap 3
  • BUN/creatinine to assess renal function 3
  • Correct serum sodium by adding 1.6 mEq/L for each 100 mg/dL glucose above 100 mg/dL 3

Initial Fluid Resuscitation (First Hour)

Adult Patients

  • Administer 0.9% NaCl at 15-20 mL/kg/h (typically 1-1.5 L) during the first hour 1, 3
  • In elderly or those with cardiac/renal compromise, use more cautious rates with closer hemodynamic monitoring 1

Pediatric Patients (<20 years)

  • Use 0.9% NaCl at 10-20 mL/kg/h 1
  • Do not exceed 50 mL/kg over the first 4 hours to minimize cerebral edema risk 1

Insulin Therapy: Critical Differences Between DKA and HHS

DKA Insulin Protocol

  • Start continuous IV regular insulin at 0.1 units/kg/h (typically 5-10 units/hour) after initial fluid resuscitation 1
  • Never start insulin if serum potassium <3.3 mEq/L—this can cause fatal cardiac arrhythmias 1
  • Continue IV insulin until resolution of ketonemia 4

HHS Insulin Protocol

  • Withhold insulin until blood glucose stops falling with IV fluids alone, unless ketonemia is present 5, 2
  • Fluid replacement alone will cause blood glucose to fall in HHS 5
  • Early insulin use before adequate fluid resuscitation may be detrimental 5
  • Once indicated, use fixed rate IV insulin infusion 2

Potassium Replacement Protocol

  • Once renal function is assured, add 20-30 mEq/L potassium to IV fluids 1, 3
  • Use 2/3 KCl and 1/3 KPO4 formulation 1, 3
  • Add potassium regardless of initial potassium level, as insulin therapy drives potassium intracellularly 1
  • Continue until patient is stable and can tolerate oral supplementation 3

Ongoing Fluid Management

After First Hour

  • Target correction of estimated deficits within 24 hours 3
  • Serum osmolality change should not exceed 3-8 mOsm/kg/h 3, 2
  • For HHS specifically, aim for osmolality reduction of 3.0-8.0 mOsm/kg/h to minimize neurological complications 2
  • An initial rise in sodium level is expected in HHS and is not itself an indication for hypotonic fluids 5

Glucose Management During Treatment

  • Add 5% or 10% glucose infusion once blood glucose falls to <200 mg/dL in DKA or <14 mmol/L (252 mg/dL) in HHS 1, 2
  • Target blood glucose 10-15 mmol/L (180-270 mg/dL) in first 24 hours for HHS 2

Monitoring Requirements

  • Monitor vital signs, mental status, fluid input/output hourly 1
  • Serial measurements of electrolytes, glucose, and acid-base status every 2-4 hours 3
  • Track hemodynamic parameters and blood pressure improvement 3
  • Calculate serum osmolality regularly to monitor treatment response 5, 2

Resolution Criteria

DKA Resolution

  • Blood glucose <200 mg/dL 1
  • Anion gap ≤12 mEq/L 1
  • Serum bicarbonate ≥15 mEq/L 1
  • Venous pH >7.3 1

HHS Resolution

  • Osmolality <300 mOsm/kg 2
  • Hypovolemia corrected (urine output ≥0.5 mL/kg/h) 2
  • Cognitive status returned to pre-morbid state 2
  • Blood glucose <15 mmol/L (270 mg/dL) 2

Transition to Subcutaneous Insulin

  • Administer basal subcutaneous insulin 2-4 hours before discontinuing IV insulin to prevent rebound hyperglycemia 1, 4
  • Common pitfall: premature termination of IV insulin or insufficient timing/dosing of subcutaneous insulin 4

Therapies to Avoid

  • Do not use bicarbonate therapy routinely—it has not been shown to improve outcomes and may worsen hypokalemia 1
  • Never rely on urine ketone testing alone for diagnosis 3
  • Avoid rapid correction of metabolic abnormalities in younger patients to decrease cerebral edema risk 6

Special Considerations

Mixed DKA/HHS Cases

  • Up to one-third of patients may have mixed features 6, 2
  • Manage using the same three-pronged approach: fluids, insulin, and electrolyte replacement 6
  • Tailor therapy according to prominent clinical features 6

Typical Deficits in DKA

  • Water: 6-9 liters 3
  • Sodium: 7-10 mEq/kg 3
  • Potassium: 3-5 mEq/kg 3
  • Chloride: 5-13 mEq/kg 3
  • Phosphate: 3-5 mmol/kg 3

HHS-Specific Considerations

  • Fluid losses typically 100-220 mL/kg (use caution in elderly) 2
  • HHS has higher mortality than DKA and develops over days rather than hours 5, 7
  • Risk of complications including myocardial infarction, stroke, seizures, cerebral edema, and central pontine myelinolysis 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.